METHODOLOGY OF PRELIMINARY CHEMOTHERAPEUTIC TRIALS IN PATIENTS WITH MALIGNANT SOLID TUMORS.
D000818:Animals; D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D001984:Bronchial Neoplasms; D003110:Colonic Neoplasms; D003520:Cyclophosphamide; D005260:Female; D005472:Fluorouracil; D006689:Hodgkin Disease; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008545:Melanoma; D009369:Neoplasms; D010051:Ovarian Neoplasms; D012004:Rectal Neoplasms; D012509:Sarcoma; D013852:Thiotepa
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D013852:Thiotepa; D005472:Fluorouracil
ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BRONCHIAL NEOPLASMS; COLONIC NEOPLASMS; CYCLOPHOSPHAMIDE; FLUOROURACIL; HODGKIN'S DISEASE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LYMPHOSARCOMA; MELANOMA; OVARIAN NEOPLASMS; RECTAL NEOPLASMS; SARCOMA, RETICULUM CELL; THIO-TEPA